GlassScriptPhysician profile
Emily Martinelli
NPI 1962961862
$941.25
in general payments reported to CMS, 2019-2025
17 companies · $360 in 2025
The $360 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2023: $72.11 · 2024: $184 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $616.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $325.00 | 2019 | |
| Baxter Healthcare | $94.75 | 2025 | Perclot |
| Biogen, INC. | $89.55 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $64.27 | 2023-2025 | Thinprep 2000 Processor, Aptima, Coolseal Generator |
| Mayne Pharma Commercial LLC | $45.31 | 2025 | |
| Abbvie INC. | $35.78 | 2023-2025 | |
| Pfizer INC. | $34.98 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $33.89 | 2024-2025 | Myfembree |
| Organon LLC | $33.63 | 2024-2025 | Nexplanon |
| Coopersurgical, INC. | $31.52 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Exeltis, USA INC. | $28.61 | 2024-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $24.56 | 2025 | |
| Agile Therapeutics, INC. | $22.80 | 2024 | Twirla |
| Pharmacosmos Therapeutics INC. | $21.20 | 2024 | Monoferric |
| Janssen Biotech, INC. | $21.07 | 2025 | Tremfya |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $19.67 | 2025 | Veozah |
| Millicent US INC | $14.66 | 2024 | Femring, Intrarosa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Martinelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.